
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

73133
10.1038/s41598-024-73133-0
Article
The correlation between serum vitamin D status and the occurrence of diabetic foot ulcers: a comprehensive systematic review and meta‐analysis
Tang Weiwei 1
Chen Dawei 1
Chen Lihong 1
Liu Guanjian 2
Sun Shiyi 1
Wang Chun 1
Gao Yun 1
Ran Xingwu ranxingwu@163.com

1
1 grid.412901.f 0000 0004 1770 1022 Innovation Research Center for Diabetic Foot, Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, 37 Guo Xue Lane, Chengdu, 610041 China
2 grid.412901.f 0000 0004 1770 1022 Chinese Cochrane Centre, Chinese EBM Centre, West China Hospital, Sichuan University, 37 Guo Xue Lane, Chengdu, 610041 China
20 9 2024
20 9 2024
2024
14 219326 4 2024
13 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The association between vitamin D concentrations and the occurrence of diabetic foot ulcers (DFUs) remains a topic of ongoing debate. In order to provide a comprehensive and updated review, we conducted this meta‐analysis to further investigate the relationship between vitamin D concentrations and DFUs occurrence. The following databases, including Cochrane Library, EMBASE, Web of Science, PubMed, CBM, CNKI, WANFANG DATA and VIP Database, were systematically searched for studies published up to Dec. 20th, 2023. The combined estimation was calculated using both fixed-effects and random‐effects models. The overall effect size was reported as a weighted mean difference (WMD) with a corresponding 95% confidence interval (95%CI). Data analysis was performed utilizing Review Manager 5.4 and Stata 14. The Protocol has been registered in PROSPERO CRD42024503468. This updated meta-analysis, incorporating thirty-six studies encompassing 11,298 individuals with or without DFUs, demonstrated a significant association between vitamin D deficiency/insufficiency and an elevated risk of DFUs occurrence (< 25 nmol/L, OR 3.28, P < 0.00001; < 50 nmol/L, OR 2.25, P < 0.00001; < 75 nmol/L, OR 1.67, P = 0.0003). Vitamin D concentrations were significantly lower in individuals with DFUs compared to those without DFUs (P < 0.00001). Subgroup analyses consistently demonstrated this trend among the older population (> 50 years, P < 0.00001), individuals with long duration of diabetes (> 10 years, P < 0.00001), and those with poor glycemic control (mean HbA1c 8%-9% and > 9%, P < 0.00001).

Keywords

Diabetic foot ulcers
Diabetes
Vitamin D
Systematic review and meta-analysis
Subject terms

Endocrinology
Diabetes
Diabetes complications
the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan UniversityZYGD18025 Ran Xingwu the West China Nursing Discipline Development Special Fund Project, Sichuan UniversityHXHL20005 Ran Xingwu Health commission of Sichuan province372 23LCYJ042 Ran Xingwu issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Current research indicates that the occurrence of diabetic foot ulcers (DFUs) isnot only associated with traditional factors, such as diabetes‐related peripheral neuropathy (DPN), peripheral arterial disease (PAD), and/or foot deformity1,2, but also with the circulating levels of micronutrients3. In recent years, there has been growing attention towards the role of vitamin D insufficiency and deficiency in DFUs4. The reasonable assumption that vitamin D status may influence the risk of DFUs occurrence is supported by emerging evidence suggesting potential involvement of vitamin D in DPN5,6 and PAD7,8, which are significant contributors to the development of DFUs1,2. Furthermore, pre-clinical studies also provide supporting evidence for a potential role of vitamin D in wound healing9,10.

However, the findings from observational studies have yielded inconsistent results. Recently, two meta-analyses11,12 have reported an inverse association between vitamin D status and DFUs. Nevertheless, these analyses may be subject to potential limitations and were underpowered. Firstly, the incorporation of Chinese-language studies has been constrained, resulting in a limited number of included studies and sample size. Secondly, considering the variability in disease states and objectives, such as osteoporosis, rickets and osteomalacia, vitamin D deficiency is defined as less than 25 nmol/L, 30 nmol/L or 50 nmol/L13. Given the inherent ambiguity surrounding the precise definition of vitamin D deficiency, it is imperative to conduct additional comprehensive investigations to elucidate the potential association between vitamin D deficiency/insufficiency and DFUs. Moreover, despite the presence of a high degree of heterogeneity among studies, sensitivity analysis and subgroup analysis were not conducted, potentially leading to the oversight of significant confounding factors. Additionally, neither of these two meta-analyses provided any information regarding the detection method for vitamin D.

Therefore, it is imperative to recommence this analysis with more rigorous and detailed protocol. Moreover, we assert that our research is more comprehensive and representative owing to the utilization of larger and updated data.

Methods

Protocol and registration

This study presents a systematic review incorporating a meta-analysis conducted in accordance with the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines14 and registered in PROSPERO (CRD42024503468). The reporting adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines15.

Data sources and searches

A comprehensive search was conducted by an experienced researcher (XR) across multiple databases, including Cochrane Library (Cochrane), EMBASE, Web of Science (WOS), PubMed, Chinese BioMedical Literature Database (CBM), CNKI, WANFANG DATA and VIP Database from inception until December 20th, 2023. The search was not limited by language restrictions. Additionally, the WHO International Clinical Trials Registry Platform was consulted to identify ongoing or unpublished potentially eligible trials that met the potential eligibility criteria. In order to ensure a comprehensive search for relevant articles, we manually examined the reference lists of identified trials and systematic reviews. The detailed search strategy can be found in Supplementary Table 1.

Study selection

The eligible studies were independently screened by two authors (WT and DC). In the event of any discrepancies, a consensus was achieved through thoroughly discussion. If an agreement could not be reached, a third experienced researcher (XR) was consulted. In accordance with the PECO strategy, we applied the following inclusion criteria: (1) Participants: adults (age ≥ 18 years) diagnosed with diabetes, irrespective of the presence or absence of DFUs; (2) Exposure: serum vitamin D concentrations (nmol/L or ng/ml) and categorization into deficient, insufficient and normal levels among study participants; (3) Comparison: the prevalence rate for vitamin D deficiency/insufficiency or variations in its levels by considering the presence or absence of DFUs; (4) Outcome: the prevalence of vitamin D deficiency/insufficiency or difference in levels of vitamin D; (5) Cross‐sectional, cohort, or case‐control studies without language or publication status restrictions. Case reports, case series, review articles, qualitative studies, and animal studies were excluded. Additionally, studies with incomplete data, incompatible formats, or non-convertible data were also excluded. The study eligibility assessment was conducted by two authors (WT and DC), with conflicts resolved through discussion with a third author (XR).

Data extraction and quality assessment

We extracted the data using predefined tables. The following information was recorded for each study: first author, year of publication, country where the study was conducted, study design, source of vitamin D in the samples, method used to determine vitamin D levels, sample size, gender distribution, vitamin D levels, age, body mass index (BMI), and HbA1c in both case and control groups. Continuous variables are depicted as mean and standard deviation (SD), categorical variables are depicted as number and percentages. For continuous variables expressed as median and interquartile range (IQR), we converted the data according to the preset method16–19, and employed estimated mean and standard deviation (SD) for the final quantitative synthesis. Study quality was assessed using the Newcastle–Ottawa quality assessment scale (NOS)20.

Data synthesis and statistical analysis

Continuous variables were pooled using the inverse variance random-effects model and were presented as mean differences with 95% CIs. Dichotomous variables were pooled using the Mantel–Haenszel method and presented as odds ratios (ORs) with 95% CI. The heterogeneity among the included studies was assessed using I2 statistics. According to the results of heterogeneity analysis, appropriate pooled methods were selected: a random‐effects model was employed if I2 > 50%, while a fixed‐effects model was adopted if I2 ≤ 50%. We evaluated the presence of publication bias through visual inspection of funnel plots and both Egger’s and Begg’s linear regression test when more than ten studies were available. To examine potential sources of heterogeneity, several a priori determined subgroup analyses were performed according to age, duration of diabetes and Hemoglobin A1c (HbA1c). Additionally, we used meta-regressions to explore potential confounders that may affect vitamin D concentrations. All data analysis was performed using Review Manager 5.4 and Stata 14, with a significance level set at 0.05.

Results

Literature search results

According to the search strategy, a total of 950 citations were initially identified from the eight databases and other sources. After removing duplicate studies (n = 302), we screened 648 potentially eligible records. Subsequently, based on title and abstract screening, 592 studies were excluded. Finally, 36 eligible studies were included in the meta-analysis. The selection process is visually depicted in Fig. 1 using a PRISMA flow diagram.Fig. 1 Flow diagram illustrating the PRISMA protocol.

Study characteristics and quality assessment

The summarized characteristics of the included trials are presented in Table 1. All studies conducted between 2009 and 2023 were of an observational nature. A total of 11,298 participants were enrolled, with 3,450 cases in the DFU group and 7,848 cases in the non-DFU group. Sample sizes ranged from 26 to 4,284 with two studies4,21 surpassing a sample size of over 1,000 participants. Out of the 36 studies included in this meta‐analysis, 31 were conducted in Asia (20 in China, 7 in India, 2 in Iran, 1 each in Indonesia and Jordan), while 4 were carried out across Europe (located respectively in Belarus, Bulgaria, Germany and Greece), and one study was conducted in North America (in the USA). Serum concentrations of 25-Hydroxyitamin D were measured across all thirty-six studies, and reported as either nmol/L or ng/ml (1 ng/mL = 2.5 nmol/L). In eighteen studies, vitamin D status of patients was categorized and prevalence rates were reported for each category. Seven different detection methods for the determination of vitamin D were recorded. The quality assessment of the included studies is presented in Supplementary Table 2.Table 1 Summary characteristics of included studies.

First author, year	Location	Study design	Language	Sample source (outpatient/inpatient)	Sample size (n)	Vitamin D assay	Mean vitamin D concentrations (nmol/L)	Male (%)	Mean age (years)	Mean BMI (kg/m2)	Mean diabetes duration (years)	Mean HbA1c (%)	
DFU	Non-DFU	Total	DFU	Non-DFU	DFU	Non-DFU	
Afarideh et al.

201622

	Iran	Cross-sectional	English	Out	Out	60	30	30	ELISA	42	40	58.3	56.8	27.7	#N/A	8.2	
Atoum et al.

202323

	Jordan	Cross-sectional	English	Out	Out	486	95	391	N	49.5	60.25	56.0	59.1	31.7	#N/A	8.5	
Bao et al.

201924

	China	N	Chinese	N	N	110	50	60	ELISA	38.23	40.08	55.5	47.9	28.5	8.0	8.0	
Chen et al.

202325

	China	N	English	N	N	160	80	80	CLIA	44	55.05	49.4	63.5	24.7	#N/A	#N/A	
Dai et al.

202026

	China	N	English	In	In	51	21	30	RIA	28.03	44.33	56.9	60.4	24.8	10.4	8.5	
Darlington et al.

201927

	India	Cross-sectional	English	Out	Out	176	88	88	ELISA	57.98	73.98	#N/A	57.3	24.4	#N/A	9.5	
Deng et al.

201528

	China	N	Chinese	In	In	120	60	60	ECL	45.1	52.2	52.5	62.7	#N/A	13.0	8.9	
Feldkamp et al.

201829

	Germany	N	English	Out/in	Out/in	207	104	103	RIA	29.5	47.5	#N/A	69.8	#N/A	17.2	#N/A	
Gupta et al.

201630

	India	N	English	Out	Out	100	50	50	RIA	35.63	53.2	63.0	52.1	23.7	4.5	9.9	
Hong et al.

201731

	China	N	Chinese	N	N	70	30	40	ELISA	38	40	#N/A	42.0	28.8	8.0	8.0	
Ignatovich et al.

201432

	Belarus	N	Russian	N	N	40	22	18	N	24.62	43.87	45.0	#N/A	#N/A	#N/A	#N/A	
Kota et al.

201333

	India	N	English	N	N	200	100	100	RIA	40.25	49.5	64.0	53.4	#N/A	#N/A	10.6	
Li et al.

202134

	China	Case–Control	Chinese	In	In	47	26	21	CL	44.15	59.48	61.7	55.0	23.3	5.3	10.5	
Li et al.

202335

	China	N	Chinese	N	N	120	60	60	CLIA	40	50.05	60.0	63.3	24.5	#N/A	#N/A	
Lu et al.

201936

	China	Case–Control	Chinese	In	In	120	60	60	CL	45.63	61.28	#N/A	61.5	#N/A	10.4	8.9	
Luo et al.

201937

	China	N	Chinese	Out	Out	80	40	40	ECL	24.45	35.78	58.8	55.0	24.6	4.7	8.2	
Najafipour et al.

201938

	Iran	N	English	N	N	70	35	35	CLIA	42.15	59.75	62.9	59.2	28.4	12.0	8.4	
Priyanto et al.

202339

	Indonesia	Cross-sectional	English	Outpatient	Outpatient	81	41	40	CLIA	21.91	40.71	39.5	56.0	26.6	7.4	8.1	
Shen et al.

201540

	China	Cross-sectional	Chinese	Out/in	Out/in	53	21	32	RIA	41.75	73	52.8	57.3	30.3	7.1	8.9	
Tang et al.

20224

	China	N	English	In	In	1721	547	1174	ECLIA	36.74	46.09	49.2	66.3	24.3	#N/A	8.0	
Tang et al.

202341

	China	N	English	In	In	256	156	100	CLIA	29.17	40.83	55.5	55.3	#N/A	7.5	9.0	
Tiwari et al.

201342

	India	N	English	N	N	289	125	164	RIA	40.25	50.75	65.1	52.1	24.4	6.1	9.6	
Tiwari et al.

201443

	India	N	English	Out	Out	219	112	107	RIA	40.2	49.4	67.6	52.8	24.0	6.6	9.4	
Tiwari et al.

202244

	India	N	English	In	In	173	100	73	RIA	40.25	49.4	#N/A	52.9	24.0	6.6	9.4	
Todorova et al.

202245

	Bulgaria	Cross-sectional	English	N	N	136	73	63	ECLIA	29.71	39.22	63.2	58.1	30.9	#N/A	8.4	
Tong et al.

202346

	China	N	Chinese	N	N	210	160	50	ELISA	24.8	37.73	55.7	60.0	#N/A	#N/A	8.7	
Tsitsou et al.

202347

	Greece	Cross-sectional	English	Out	Out	68	33	35	LC–MS/MS	44.75	49.5	75.0	64.1	29.7	15.7	6.9	
Wang et al.

2022a48

	China	N	English	In	In	429	242	187	ECLIA	28.28	37.78	64.3	62.3	24.9	14.8	8.7	
Wang et al.

2022b49

	China	N	English	In	In	339	204	135	N	30.49	38.14	62.8	67.2	24.5	17.2	8.5	
Wang et al.

2022c50

	China	N	Chinese	N	N	160	80	80	CL	47.18	56.03	74.4	64.9	25.0	11.4	9.9	
Wu et al.

201551

	China	N	Chinese	N	N	48	24	24	ELISA	25.8	31.7	58.3	55.5	#N/A	8.9	8.9	
Xiao et al.

202021

	China	Cross-sectional	English	In	In	4284	245	4039	CL	36.96	40.97	52.6	#N/A	#N/A	#N/A	#N/A	
Yoho et al.

200952

	USA	N	English	N	N	26	13	13	N	35.2	43.45	73.1	63.6	#N/A	#N/A	#N/A	
Zhang et al.

201353

	China	N	Chinese	In	In	85	41	44	ELISA	26.56	32.23	70.6	56.5	24.5	12.6	8.9	
Zhang et al.

202254

	China	N	Chinese	In	In	180	120	60	ECL	24.55	37.55	64.4	55.4	24.4	#N/A	8.6	
Zubair et al.

201355

	India	Prospective cohort	English	In	In	324	162	162	RIA	20.56	74.68	63.3	46.7	24.4	#N/A	8.8	
CL chemiluminescence; CLIA chemiluminescent immunoassay; ECL electrochemiluminescence; ECLIA electrochemiluminescent immunoassay; ELISA enzyme-linked immunosorbent assay; LC–MS/MS liquid chromatography-tandem mass spectrometry; RIA radioimmunoassay; N not reported.

Variations in vitamin D concentrations and their impact on DFUs

Given the lack of consensus regarding the definition of vitamin D deficiency or insufficiency, we classified vitamin D concentrations into three distinct thresholds based on available data from the included studies, namely vitamin D < 25 nmol/L as Grade A, vitamin D < 50 nmol/L as Grade B and vitamin D < 75 nmol/L as Grade C.

Seven studies yielded data on vitamin D concentrations below 25 nmol/L, with 253 (45.59%) individuals with DFUs and 122 (20.37%) individuals with both diabetes and non-DFUs having concentrations of vitamin D below this threshold. The findings demonstrate a significant association between vitamin D concentrations below 25 nmol/L and the risk of developing DFUs (OR 3.28, 95% CI [2.52, 4.27], P < 0.00001; I2 = 0%, P-heterogeneity = 0.43) (Fig. 2A). As depicted in Fig. 2B, a total of 1545 (77.10%) patients with DFUs and 4317 (65.56%) individuals without DFUs exhibited vitamin D concentrations below 50 nmol/L across thirteen studies, which was also associated with an elevated risk of DFUs (OR 2.25, 95% CI [1.80, 2.80], P < 0.00001; I2 = 55%, P-heterogeneity = 0.009) (Fig. 2B). The absence of publication bias was indicated by the funnel plot as well as the Egger and Begg tests (Egger P = 0.252, Begg P = 0.246) (Supplementary Fig. 2B). In relation to vitamin D concentrations below 75 nmol/L, a total of ten studies involving 253 (45.59%) patients in the DFUs group and 122 (20.37%) patients in the non-DFUs control group were identified. Notably, a statistically significant disparity persisted in the incidence of DFUs between these two groups (OR 1.67, 95% CI [1.26, 2.20], P = 0.0003; I2 = 21%, P-heterogeneity = 0.25) (Fig. 2C). The analysis of bias tests using funnel plots, Egger and Begg tests did not reveal any significant publication bias (Egger P = 0.085, Begg P = 0.283) (Supplementary Fig. 2C).Fig. 2 A, B, C Forest plot illustrating the association between DFUs and varying thresholds of vitamin D levels. A: 25 nmol/L, B: 50 nmol/L, C: 75 nmol/L. df, degrees of freedom; IV, inverse variance; M-H, Mantel–Haenszel.

Vitamin D concentrations and DFUs

As depicted in Fig. 3A, the meta-analysis employed a random-effects model to analyze all 36 studies. The findings demonstrated a significant reduction in serum vitamin D levels among patients with DFUs compared to individuals without DFUs (WMD =  − 10.80, 95% CI [− 11.89, − 9.71], P < 0.00001). The heterogeneity tests indicated substantial heterogeneity among the included studies (I2 = 88%, P-heterogeneity < 0.00001). The absence of asymmetry observed in the funnel plot (Fig. 3B) analysis suggests no evidence of publication bias. Furthermore, both the Egger test (P = 0.44) and Begg test (P = 0.205) did not identify any significant small study effects.Fig. 3 A Forest plot illustrating the vitamin D concentrations in patients with DFUs or non-DFUs. B Funnel plot illustrating the vitamin D concentrations in patients with DFUs or non-DFUs.

The heterogeneity observed in this study was not attributed to any individual study, and a total of eight studies21,24,25,31,35,39,40,55 with a high risk of bias were identified. However, excluding these eight studies that contributed the most to between-study heterogeneity did not significantly alter the results (WMD =  − 10.93, 95% CI [− 12.20, − 9.65], P < 0.00001). Furthermore, this exclusion led to a substantial reduction in heterogeneity (I2 = 52%, P-heterogeneity = 0.0007) (Supplementary Fig. 3).

Subgroup analysis

Subgroup analysis was conducted to evaluate the potential interaction between vitamin D and other factors.

Initially, variations in the association between vitamin D and DFUs were observed across different age groups. Among studies with a mean age of 50 years or younger, there was no statistically significant difference in vitamin D concentrations between patients with DFUs and individuals without DFUs (WMD =  − 18.77, 95% CI [− 38.77, 1.23], P = 0.07; I2 = 99%, P-heterogeneity < 0.00001). However, in individuals aged over 50 years, the DFUs group exhibited significantly lower vitamin D concentrations compared to the non-DFUs group. Notably, heterogeneity decreased across studies without reaching statistical significance for interaction (WMD =  − 10.95, 95% CI [− 11.77, − 10.13], P < 0.00001; I2 = 70%, P-heterogeneity < 0.00001; P-interaction = 0.44) (Supplementary Fig. 4).

The results demonstrated robustness and consistency across various subgroups based on the duration of diabetes, thereby highlighting their generalizability. Furthermore, a notable reduction in heterogeneity was observed specifically within the subgroup characterized by an average diabetes duration exceeding 10 years (WMD =  − 10.48, 95% CI [− 13.31, − 7.64], P < 0.00001; I2 = 60%, P-heterogeneity = 0.008) (Supplementary Fig. 5).

Considering the potential interaction between vitamin D concentrations and glycemic control, we further stratified mean HbA1c values into three subgroups (≤ 8%, 8–9% or > 9%). Upon comparing these three subgroups, no significant difference in vitamin D concentrations was observed in patients with or without DFUs when mean HbA1c was less than or equal to 8% (mean HbA1c ≤ 8%, WMD =  − 2.06, 95% CI [− 4.18, 0.06], P = 0.06; I2 = 0%, P-heterogeneity = 0.84). However, the vitamin D concentrations were significantly lower in the DFUs group compared to the non-DFUs group, when mean HbA1c values were ranging from 8 to 9% (mean HbA1c 8%-9%, WMD =  − 13.63, 95% CI [− 16.51, − 10.76], P < 0.00001; I2 = 89%, P-heterogeneity < 0.00001). In subgroup analysis involving individuals with mean HbA1c values greater than 9%, those with DFUs exhibited significantly lower vitamin D concentrations compared to those without DFUs, and heterogeneity between studies was reduced (mean HbA1c > 9%, WMD =  − 9.38, 95% CI [− 10.37, − 8.39], P < 0.00001; I2 = 0%, P-heterogeneity = 0.51). Furthermore, a significant interaction was observed among the three subgroups based on mean HbA1c values (P-interaction < 0.00001) (Supplementary Fig. 6).

Additionally, the meta-regression analysis investigating the influence of geographical location, gender, BMI and research quality on the risk of DFUs did not yield statistically significant results.

Discussion

This meta-analysis of thirty-six observational studies, encompassing patients with or without DFUs, revealed a significant correlation between vitamin D insufficiency and deficiency, and an elevated risk of developing DFUs. Furthermore, lower serum concentrations of vitamin D were found to be associated with an increased susceptibility to DFUs. Additionally, our meta-analysis found a significant association between low serum vitamin D levels and the presence of DFUs. This association was particularly pronounced in older patients with longer diabetes duration and poorer glycemic control.

Although several single-center randomized controlled trials (RCTs)56–60 with a limited sample size have been conducted, the current evidence on this topic primarily relies on observational studies. Therefore, it is important to emphasize that our findings do not necessarily establish a direct causal relationship between vitamin D and DFUs. It is worth noting that there are two evident confounding factors that imped causal inference. Firstly, it is well-established that vitamin D synthesis primarily occurs in the skin following exposure to ultraviolet B radiation from sunlight61. Therefore, engaging in appropriate outdoor activities becomes crucial for maintaining normal serum vitamin D levels. The decline in outdoor activities among patients with DFUs and those at high risk cannot be overlooked, as it may contribute to the observed low serum vitamin D levels. Secondly, a significant inverse association has been reported between serum vitamin D and obesity62, which is particularly relevant considering the majority of type 2 diabetic patients are overweight or obese. However, numerous significant potential mechanisms revealed by preclinical studies may hypothetically elucidate the augmented risk of DFUs in individuals with both diabetes and low vitamin D concentrations. Firstly, vitamin D plays a pivotal role in regulating the proliferation, migration, and differentiation of keratinocytes. In addition to serving as the primary source of vitamin D, the keratinocytes in the epidermis and hair follicle express all the necessary enzymes for vitamin D metabolism63. Conditional VDR knockout mice exhibit impaired self-renewal, activation, and migration of epidermal stem cells due to inhibition of β-catenin signaling, resulting in delayed re-epithelialization and wound closure64. Furthermore, topical application of vitamin D has been demonstrated to enhance wound healing65. Additionally, vitamin D plays a pivotal role in modulating immune and inflammatory responses. Supplementation with vitamin D can attenuate the expression of proinflammatory cytokines such as IL-6, IL-1β, MCP-1 and TNFα by inhibiting AMPK activation and nuclear NF-κB phosphorylation66. On the contrary, the normal inflammatory response is facilitated through interaction with the TGF-β signaling pathway and enhancement of VDR-Smad3 complex formation67. Besides, vitamin D exerts its influence on the innate immune system by impacting antigen-presenting cells (APC) and inducing expression of antimicrobial peptides (AMPs)68, while also regulating adaptive immunity by modulating the activities of T-helper cells, T-regulatory cells and B cells69. Thirdly, it can enhance angiogenesis by upregulating the expression of pro-angiogenic factors such as vascular endothelial growth factor A, hypoxia-inducible factor-1α and angiogenin70. Moreover, vitamin D deficiency may contribute to clinical diabetic small fibre neuropathy through its impact on nerve growth factor (NGF), which governs phenotype and sensitivity of nociceptor fibres71, while chronic administrations of vitamin D has been shown to alleviate behavioral scores associated with neuropathic pain in rats72. These mechanisms substantiate the ongoing interest among clinical researchers in exploring the relationship between vitamin D and DFUs, thereby highlighting the increasing attention garnered by the clinical significance of vitamin D supplementation in DFUs. Therefore, despite the potential influence of various factors such as outdoor activities and obesity on serum vitamin D levels in patients with DFUs, pertinent data from preclinical investigations still substantiate the plausible causal roles of vitamin D in the pathophysiology of DFUs.

However, the current available observational studies on vitamin D and DFUs have yielded inconsistent findings. While the majority of studies indicated lower vitamin D concentrations in patients with DFUs compared to those without DFUs, a minority of others conducted in India27, Greece47 and China31,73 reported no statistically significant difference. Interestingly, a cross-sectional study conducted in Iran22 even yielded conflicting findings. Notably, in 2019, Jiezhi Dai et al.74 performed the inaugural meta-analysis on this subject matter, encompassing seven studies involving 1,115 patients. Their analysis revealed a significant decrease in vitamin D levels among patients with DFUs (MD − 13.47 nmol/L, 95% CI [− 16.84, − 10.10], P < 0.00001; P-heterogeneity = 0.34, I2 = 12%) and established an association between severe vitamin D deficiency and an elevated risk of DFUs (OR 3.22, 95% CI [2.42 − 4.28], P < 0.00001; P-heterogeneity = 0.64, I2 = 0%). However, the limited number of included studies and inadequate sample size of researched objects constrain the strength of their evidence. In recent years, two similar meta-analyses have been reported11,12. However, regrettably, neither of them encompassed studies published in Chinese. Moreover, studies yielding non-significant results27,31,73 were also excluded, potentially introducing bias. Additionally, the lack of standardization in the units used for vitamin D measurements in these two reviews may potentially impact the reliability of results. For instance, Xin Li et al.’s11 meta-analysis published in 2023 reported vitamin D concentrations as ng/ml in six out of fifteen included studies26,39,41,44,45,47, while others utilized nmol/L. Furthermore, in another meta-analysis conducted by Juan Lin et al.12 during the same year, there were inaccuracies in evaluating sample sizes for two of twelve studies included55,75. Lastly, the high heterogeneity observed across studies highlighted by both reviews was not addressed through subgroup or meta-regression analysis. This oversight may have overlooked significant potential confounding factors.

There are two significant distinctions between previous reports and our study. Firstly, we conducted a comprehensive evaluation of all relevant studies published in Chinese, which were included in the current analysis. Additionally, we incorporated three recently published studies from Oct 2023 with an aggregate sample size exceeding 800 patients that were previously unavailable for inclusion. These additions facilitated the acquisition of more extensive data, thereby enhancing statistical power. Secondly, to investigate potential sources of heterogeneity, we performed sensitivity, subgroup analyses, and meta‐regression analyses to augment the credibility and reliability of our findings. Furthermore, by implementing more detailed grading system for vitamin D concentrations, we aimed to explore any possible linear relationship between vitamin D levels and the risk of DFUs.

In addition to conventional comparison, given the substantial heterogeneity (I2 = 88%) observed in the overall forest plot and the multitude of influencing factors associated with vitamin D, we further conducted subgroup analyses based on age, duration of diabetes, and glycemic control.

An intriguing finding from the subgroup analysis based on age is that a significant disparity in vitamin D levels was observed only among individuals aged 50 years or older (P < 0.00001), whereas no such difference was found in patients younger than 50 years (P = 0.07). Furthermore, the heterogeneity (I2 = 70%) substantially decreased within the subgroup of older patients (> 50 years), although no statistically significant differences were observed between subgroups (P > 0.05). The decline in vitamin D concentrations with advancing age can be attributed to various factors, including variations in dietary intake, metabolic dysfunctions, and diminished vitamin D receptors76,77. Consequently, there is a significant degree of interindividual variation in vitamin D concentrations, which tends to increase with advancing age. Notably, perimenopausal and postmenopausal women exhibit a higher prevalence of lower serum levels of vitamin D78, potentially contributing to inconsistent findings observed across different age subgroups.

In the subgroup analysis of varying durations of diabetes, patients with DFUs exhibited comparatively lower concentrations of vitamin D compared to those without DFUs in the subgroup with a disease duration exceeding 10 years, resulting in a significant reduction in heterogeneity among studies. These findings suggest that the duration of diabetes may contribute to the observed heterogeneity.

In the subgroup analysis of different glycemic control statuses, a statistically significant difference in vitamin D levels was only observed in the population with poor blood sugar control (mean HbA1c 8%-9% and > 9%, P < 0.00001), but not in those with acceptable glycemic control (mean HbA1c ≤ 8%, P = 0.06), accompanying with a significant differences between the subgroups (P-interaction < 0.00001). Actually, the impact of vitamin D on glycemic control continues to garner attention, as evidenced by a recent RCT demonstrating its preservation of vitamin D on pancreatic β-cell function79. Overall, Vitamin D supplementation has been shown to have a beneficial effect in reducing insulin resistance80 and improving glycemic control81. This finding partially elucidates why significant disparities in vitamin D levels were observed solely among individuals with suboptimal glycemic control.

Furthermore, we conducted a comprehensive meta-regression analysis accounting for potential confounding factors such as geographical location, gender, BMI and research quality that could potentially impact the outcomes of vitamin D studies. However, despite our diligent efforts, we did not find any significant associations. Unfortunately, owing to the unavailability of data, we were unable to account for several potentially significant confounding factors, including blood draw season, diabetes medication usage, physical activity levels and duration of outdoors exposure during summer. Additionally, it is worth noting that vitamin D receptor polymorphism also exerts a crucial influence on both vitamin D status and vitamin D metabolism82,83.

We conducted comprehensive subgroup and sensitivity analyses to thoroughly investigate the sources of heterogeneity, and our results remained robust even after adjusting for confounding factors or conducting additional sensitivity analyses. Based on these findings, it is imperative to consider implementing routine screening for vitamin D concentrations in individuals with diabetes, particularly those with DFUs. Furthermore, it is advisable to administer vitamin D supplementations to individuals exhibiting inadequate or deficient levels of this nutrient, particularly among elderly patients with long-standing diabetes and suboptimal glycemic control. Based on animal models, the latest research findings84,85 support the involvement of vitamin D in wound healing, while there remains a debate regarding routine vitamin D supplementation in patients with DFUs. However, careful consideration must be given while interpreting findings derived from subgroup analysis and meta-regression utilizing average indicators due to the absence of individual-level data. For instance, it should be noted that studies involving participants with a mean age of 50 years or younger may also include individuals aged over 50 years in both DFUs and non-DFUs groups. Conversely, a similar situation could arise in subgroups with a mean age exceeding 50 years. Therefore, caution should be exercised when interpreting the findings derived from subgroup analysis and meta-regression.

However, it is crucial to meticulously consider several limitations of the present study. Firstly, the analysis was solely conducted on trial-level data, without access to individual-level data. This limitation also applies to the subgroup analysis. For example, our subgroup analysis relied on mean HbA1c values in order to ascertain whether the disparity in vitamin D concentrations is confined to subjects with poor glycemic control. However, the inclusion of individual-level data would enhance its reliability and strengthen the findings. Secondly, due to limited available data, a comprehensive investigation into sources of heterogeneity was not possible. Consequently, potential confounding factors such as ulcers severity, dietary habits, and other variables could not be adequately accounted for. It is important to note that these included studies encompassed both outpatients and inpatients, while those with inpatients may introduce bias towards more severe ulcers. Thirdly, there was a lack of consistency in the methodology employed for assessing serum vitamin D concentrations across the studies included, as several studies omitted reporting this crucial information. Additionally, there was a substantial variation in absolute values of vitamin D concentrations among the included studies. Fourthly, the utilization of case–control and cross‐sectional designs instead of RCTs hindered the establishment of causal relationship. Moreover, the imprecise temporal sequence between the occurrence of DFUs and assessment of vitamin D status also limited the ability to establish causality. Therefore, it is crucial to interpret these findings with caution.

Conclusions

The findings of this meta-analysis suggest that patients with DFUs exhibit lower serum vitamin D concentrations compared to those without DFUs, particularly among the elderly population with long-standing diabetes and poor glycemic control. Vitamin D deficiency and insufficiency may potentially contribute to the increased susceptibility to developing DFUs. However, the causal relationship between vitamin D status and DFUs remains unclear. Given the underlying supporting mechanisms, this clinical issue holds significant practical implications. Therefore, if maintaining adequate vitamin D concentrations proves beneficial in preventing DFUs, vitamin D supplementation could serve as a safe, cost-effective, and widely accessible potential therapeutic approach for individuals with DFUs. Nevertheless, further investigation is warranted to establish a definitive causal association between vitamin D status and the development of DFUs.

Supplementary Information

Supplementary Information.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-73133-0.

Acknowledgements

This study was financially supported by the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University [Grant No. ZYGD18025], the West China Nursing Discipline Development Special Fund Project, Sichuan University [Grant No. HXHL20005], and Health commission of Sichuan province (Grant No. 372 23LCYJ042).

Author contributions

XR and WT devised the research plan, demonstrating their expertise in study design. WT and DC conducted a comprehensive review of relevant studies, ensuring a thorough examination of existing literature, and meticulously extracted the data with great attention to detail. GL and WT performed rigorous data analysis using advanced statistical methods, enhancing the reliability of the findings. The manuscript was skillfully composed by WT, showcasing her proficiency in scientific writing. LC, SS, CW and YG diligently revised the manuscript to improve its clarity and coherence. All authors have thoroughly reviewed and given their approval to the final version of this scholarly work.

Funding

The 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, (Grant no: ZYGD18025); the West China Nursing Discipline Development Special Fund Project, Sichuan University, (Grant no: HXHL20005); Health commission of Sichuan province (Grant no: 372 23LCYJ042).

Data availability

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Declarations

Competing interests

The authors declare no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors are the co-first author: Weiwei Tang and Dawei Chen.
==== Refs
References

1. Bus SA Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) Diabetes Metab. Res. Rev. 2023 2023 e3651
Bus, S. A. et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab. Res. Rev. 2023, e3651 (2023).
2. Schaper NC Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update) Diabetes Metab. Res. Rev. 2023 2023 e3657
Schaper, N. C. et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab. Res. Rev. 2023, e3657 (2023).
3. Kurian SJ The association between micronutrient levels and diabetic foot ulcer: A systematic review with meta-analysis Front. Endocrinol. (Lausanne) 2023 14 1152854 10.3389/fendo.2023.1152854 37065742
Kurian, S. J. et al. The association between micronutrient levels and diabetic foot ulcer: A systematic review with meta-analysis. Front. Endocrinol. (Lausanne) 14, 1152854 (2023).37065742
4. Tang W Association between vitamin D status and diabetic foot in patients with type 2 diabetes mellitus J. Diabetes Invest. 2022 10.1111/jdi.13776
Tang, W. et al. Association between vitamin D status and diabetic foot in patients with type 2 diabetes mellitus. J. Diabetes Invest.10.1111/jdi.13776 (2022).
5. Li K How vitamins act as novel agents for ameliorating diabetic peripheral neuropathy: A comprehensive overview Ageing Res. Rev. 2023 91 102064 10.1016/j.arr.2023.102064 37689144
Li, K. et al. How vitamins act as novel agents for ameliorating diabetic peripheral neuropathy: A comprehensive overview. Ageing Res. Rev. 91, 102064 (2023).37689144
6. Pang C Vitamin D and diabetic peripheral neuropathy: A multi-centre nerve conduction study among Chinese patients with type 2 diabetes Diabetes Metab. Res. Rev. 2023 39 7 e3679 10.1002/dmrr.3679 37337761
Pang, C. et al. Vitamin D and diabetic peripheral neuropathy: A multi-centre nerve conduction study among Chinese patients with type 2 diabetes. Diabetes Metab. Res. Rev. 39(7), e3679 (2023).37337761
7. Yuan J Vitamin D deficiency is associated with risk of developing peripheral arterial disease in type 2 diabetic patients BMC Cardiovasc. Disord. 2019 19 1 145 10.1186/s12872-019-1125-0 31208330
Yuan, J. et al. Vitamin D deficiency is associated with risk of developing peripheral arterial disease in type 2 diabetic patients. BMC Cardiovasc. Disord. 19(1), 145 (2019).31208330
8. Hammad R Non-classical monocytes frequency and serum vitamin D(3) levels are linked to diabetic foot ulcer associated with peripheral artery disease J. Diabetes Invest. 2023 10.1111/jdi.14048
Hammad, R. et al. Non-classical monocytes frequency and serum vitamin D(3) levels are linked to diabetic foot ulcer associated with peripheral artery disease. J. Diabetes Invest.10.1111/jdi.14048 (2023).
9. Bikle D Christakos S New aspects of vitamin D metabolism and action - addressing the skin as source and target Nat. Rev. Endocrinol. 2020 16 4 234 252 10.1038/s41574-019-0312-5 32029884
Bikle, D. & Christakos, S. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Nat. Rev. Endocrinol. 16(4), 234–252 (2020).32029884
10. Bikle DD Role of vitamin D and calcium signaling in epidermal wound healing J. Endocrinol. Invest. 2023 46 2 205 212 10.1007/s40618-022-01893-5 35963983
Bikle, D. D. Role of vitamin D and calcium signaling in epidermal wound healing. J. Endocrinol. Invest. 46(2), 205–212 (2023).35963983
11. Li X The relationship between vitamin D deficiency and diabetic foot ulcer: A meta-analysis Int. Wound J. 2023 10.1111/iwj.14177 38156707
Li, X. et al. The relationship between vitamin D deficiency and diabetic foot ulcer: A meta-analysis. Int. Wound J.10.1111/iwj.14177 (2023).38156707
12. Lin J Association between vitamin D deficiency and diabetic foot ulcer wound in diabetic subjects: A meta-analysis Int. Wound J. 2023 20 1 55 62 10.1111/iwj.13836 35567425
Lin, J. et al. Association between vitamin D deficiency and diabetic foot ulcer wound in diabetic subjects: A meta-analysis. Int. Wound J. 20(1), 55–62 (2023).35567425
13. Bertoldo F Definition, assessment, and management of Vitamin D inadequacy: suggestions, recommendations, and warnings from the italian society for osteoporosis, mineral metabolism and bone diseases (SIOMMMS) Nutrients 2022 14 19 4148 10.3390/nu14194148 36235800
Bertoldo, F. et al. Definition, assessment, and management of Vitamin D inadequacy: suggestions, recommendations, and warnings from the italian society for osteoporosis, mineral metabolism and bone diseases (SIOMMMS). Nutrients 14(19), 4148 (2022).36235800
14. Stroup DF Meta-analysis of observational studies in epidemiology: a proposal for reporting JAMA 2000 283 15 2008 2012 10.1001/jama.283.15.2008 10789670
Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15), 2008–2012 (2000).10789670
15. Liberati A The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann. Intern. Med. 2009 151 4 W65 94 10.7326/0003-4819-151-4-200908180-00136 19622512
Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann. Intern. Med. 151(4), W65-94 (2009).19622512
16. Shi J Detecting the skewness of data from the five-number summary and its application in meta-analysis Stat. Methods Med. Res. 2023 32 7 1338 1360 10.1177/09622802231172043 37161735
Shi, J. et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat. Methods Med. Res. 32(7), 1338–1360 (2023).37161735
17. Wan X Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range BMC Med. Res. Methodol. 2014 14 135 10.1186/1471-2288-14-135 25524443
Wan, X. et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 14, 135 (2014).25524443
18. Luo D Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range Stat. Methods Med. Res. 2018 27 6 1785 1805 10.1177/0962280216669183 27683581
Luo, D. et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat. Methods Med. Res. 27(6), 1785–1805 (2018).27683581
19. Shi J Optimally estimating the sample standard deviation from the five-number summary Res. Synth. Methods 2020 11 5 641 654 10.1002/jrsm.1429 32562361
Shi, J. et al. Optimally estimating the sample standard deviation from the five-number summary. Res. Synth. Methods 11(5), 641–654 (2020).32562361
20. Wells G.A., et al., The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute 2011. p1–12.
21. Xiao Y Association between vitamin D status and diabetic complications in patients with type 2 diabetes mellitus: A cross-sectional study in Hunan China Front. Endocrinol. (Lausanne) 2020 11 564738 10.3389/fendo.2020.564738 33042022
Xiao, Y. et al. Association between vitamin D status and diabetic complications in patients with type 2 diabetes mellitus: A cross-sectional study in Hunan China. Front. Endocrinol. (Lausanne) 11, 564738 (2020).33042022
22. Afarideh M Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers Br. J. Nutr. 2016 115 11 1938 1946 10.1017/S0007114516001094 27153203
Afarideh, M. et al. Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers. Br. J. Nutr. 115(11), 1938–1946 (2016).27153203
23. Atoum MF Relationship of serum vitamin D levels with diabetic foot in patients with type 2 diabetes mellitus: A cross-sectional study Int. J. Low Extrem. Wounds 2023 10.1177/15347346231205641 37792565
Atoum, M. F. et al. Relationship of serum vitamin D levels with diabetic foot in patients with type 2 diabetes mellitus: A cross-sectional study. Int. J. Low Extrem. Wounds10.1177/15347346231205641 (2023).37792565
24. Bao C Clinical analysis of 25-hydroxyvitamin D, D-dimer, glycosylated hemoglobin and type 2 diabetic foot Feet Health Care. 2019 28 03 49 50
Bao, C. Clinical analysis of 25-hydroxyvitamin D, D-dimer, glycosylated hemoglobin and type 2 diabetic foot. Feet Health Care. 28(03), 49–50 (2019).
25. Chen X Analysis of the association between serum levels of 25(OH)D, retinol binding protein, and Cyclooxygenase-2 and the disease severity in patients with diabetic foot ulcers Int. Wound J. 2023 10.1111/iwj.14502 38158884
Chen, X. et al. Analysis of the association between serum levels of 25(OH)D, retinol binding protein, and Cyclooxygenase-2 and the disease severity in patients with diabetic foot ulcers. Int. Wound J.10.1111/iwj.14502 (2023).38158884
26. Dai J Association between serum 25-OH-vitamin D and diabetic foot ulcer in patients with type 2 diabetes Front. Nutr. 2020 7 109 10.3389/fnut.2020.00109 32984392
Dai, J. et al. Association between serum 25-OH-vitamin D and diabetic foot ulcer in patients with type 2 diabetes. Front. Nutr. 7, 109 (2020).32984392
27. Danny Darlington CJ Evaluation of serum vitamin D levels in diabetic foot infections: A cross-sectional study in a tertiary care center in South India Iran J. Med. Sci. 2019 44 6 474 482 31875082
Danny Darlington, C. J. et al. Evaluation of serum vitamin D levels in diabetic foot infections: A cross-sectional study in a tertiary care center in South India. Iran J. Med. Sci. 44(6), 474–482 (2019).31875082
28. Deng H The effects of vitamin D deficiency on patients with diabetic foot infection Chin. J. Prev. Control Chronic Dis. 2015 23 10 743 745
Deng, H. et al. The effects of vitamin D deficiency on patients with diabetic foot infection. Chin. J. Prev. Control Chronic Dis. 23(10), 743–745 (2015).
29. Feldkamp J Severe vitamin D3 deficiency in the majority of patients with diabetic foot ulcers Horm. Metab. Res. 2018 50 8 615 619 10.1055/a-0648-8178 29975973
Feldkamp, J. et al. Severe vitamin D3 deficiency in the majority of patients with diabetic foot ulcers. Horm. Metab. Res. 50(8), 615–619 (2018).29975973
30. Gupta B, S.K.S., In vitro study of role of vitamin D on macrophages dysfunction in patients with diabetic foot infection. Int. J. Adv. Res. (2016).
31. Hong G Clinical research of 25-hydroxyvitamin D, D-dimer, glycosylated hemoglobin and diabetic foot China Practical Med. 2017 12 02 4 6
Hong, G. et al. Clinical research of 25-hydroxyvitamin D, D-dimer, glycosylated hemoglobin and diabetic foot. China Practical Med. 12(02), 4–6 (2017).
32. Ignatovich, I.N., Kondratenko, G.G. & Dobrovol’skaia Iu, V. [Low level of 25-OH-vitamin D as a marker of critical ischemia in case of diabetic foot syndrome]. Khirurgiia (Mosk) 2014(3), 11–14.
33. Kota, Inflammatory markers in diabetic foot and impact of vitamin D deficiency. 2013.
34. Li Q Analysis of serum hepcidin levels and related in patients with diabetic lower extremity vascular disease and foot ulcer J. Chin. Phys. 2021 23 5 674 678
Li, Q. et al. Analysis of serum hepcidin levels and related in patients with diabetic lower extremity vascular disease and foot ulcer. J. Chin. Phys. 23(5), 674–678 (2021).
35. Li R Correlation analysis of serum 25(OH)D, RBP, COX-2 levels and disease severity in elderly diabetic foot patients Int. J. Lab. Med. 2023 44 07 884 886
Li, R. et al. Correlation analysis of serum 25(OH)D, RBP, COX-2 levels and disease severity in elderly diabetic foot patients. Int. J. Lab. Med. 44(07), 884–886 (2023).
36. Lu, A., et al. The relationship between neurotic foot ulcers and serum vitamin D in type 2 diabetes mellitus. J. Inner Mongolia Med. Univ. 41(04), 399–401+404 (2019).
37. Luo L Relationship between serum TLR9 and 25-hydroxyvitamin D in patients with type 2 diabetic foot ulcer Chin. J. Diabetes. 2019 27 06 413 416
Luo, L. et al. Relationship between serum TLR9 and 25-hydroxyvitamin D in patients with type 2 diabetic foot ulcer. Chin. J. Diabetes. 27(06), 413–416 (2019).
38. Najafipour F Role of serum vitamin D level in progression of diabetic foot ulcer J. Clin. Diagn. Res. 2019 10.7860/JCDR/2019/39974.12689
Najafipour, F. et al. Role of serum vitamin D level in progression of diabetic foot ulcer. J. Clin. Diagn. Res.10.7860/JCDR/2019/39974.12689 (2019).
39. Priyanto MH Comparison of vitamin D levels in diabetes mellitus patients with and without diabetic foot ulcers: An analytical observational study in Jakarta, Indonesia Int. Wound J. 2023 20 6 2028 2036 10.1111/iwj.14066 36647686
Priyanto, M. H. et al. Comparison of vitamin D levels in diabetes mellitus patients with and without diabetic foot ulcers: An analytical observational study in Jakarta, Indonesia. Int. Wound J. 20(6), 2028–2036 (2023).36647686
40. Shen H Association between serum vitamin D and diabetic foot risk J. Gannan Med. Univ. 2015 35 02 261 264
Shen, H. et al. Association between serum vitamin D and diabetic foot risk. J. Gannan Med. Univ. 35(02), 261–264 (2015).
41. Tang Y Level of 25-hydroxyvitamin D and vitamin D receptor in diabetic foot ulcer and factor associated with diabetic foot ulcers Diabetol. Metab. Syndr. 2023 15 1 30 10.1186/s13098-023-01002-3 36829206
Tang, Y. et al. Level of 25-hydroxyvitamin D and vitamin D receptor in diabetic foot ulcer and factor associated with diabetic foot ulcers. Diabetol. Metab. Syndr. 15(1), 30 (2023).36829206
42. Tiwari S Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection Br. J. Nutr. 2013 109 1 99 102 10.1017/S0007114512000578 22715859
Tiwari, S. et al. Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection. Br. J. Nutr. 109(1), 99–102 (2013).22715859
43. Tiwari S Vitamin D deficiency is associated with inflammatory cytokine concentrations in patients with diabetic foot infection Br. J. Nutr. 2014 112 12 1938 1943 10.1017/S0007114514003018 25331710
Tiwari, S. et al. Vitamin D deficiency is associated with inflammatory cytokine concentrations in patients with diabetic foot infection. Br. J. Nutr. 112(12), 1938–1943 (2014).25331710
44. Tiwari S Association of vitamin D with macrophage migration inhibitory factor and interleukin-8 in diabetic foot infection Chron. Diabetes Res. Practice 2022 10.4103/cdrp.cdrp_6_21
Tiwari, S. et al. Association of vitamin D with macrophage migration inhibitory factor and interleukin-8 in diabetic foot infection. Chron. Diabetes Res. Practice10.4103/cdrp.cdrp_6_21 (2022).
45. Todorova AS Vitamin D status in a bulgarian population with type 2 diabetes and diabetic foot ulcers Int. J. Low Extrem. Wounds 2022 21 4 506 512 10.1177/1534734620965820 33094656
Todorova, A. S. et al. Vitamin D status in a bulgarian population with type 2 diabetes and diabetic foot ulcers. Int. J. Low Extrem. Wounds 21(4), 506–512 (2022).33094656
46. Tong L Association of serum TGF-β1, 25(OH) vitamin D and vitamin B12 levels with disease severity and healing rate of patients with diabetic foot ulcer J. North Sichuan Med. College. 2023 38 10 1358 1361
Tong, L. et al. Association of serum TGF-β1, 25(OH) vitamin D and vitamin B12 levels with disease severity and healing rate of patients with diabetic foot ulcer. J. North Sichuan Med. College. 38(10), 1358–1361 (2023).
47. Tsitsou S Evaluation of vitamin D levels in patients with diabetic foot ulcers Int. J. Low Extrem. Wounds 2023 22 1 27 35 10.1177/1534734620984584 33390083
Tsitsou, S. et al. Evaluation of vitamin D levels in patients with diabetic foot ulcers. Int. J. Low Extrem. Wounds 22(1), 27–35 (2023).33390083
48. Wang F A retrospective analysis of the relationship between 25-OH-vitamin D and diabetic foot ulcer Diabetes Metab. Syndr. Obes. 2022 15 1347 1355 10.2147/DMSO.S358170 35535217
Wang, F. et al. A retrospective analysis of the relationship between 25-OH-vitamin D and diabetic foot ulcer. Diabetes Metab. Syndr. Obes. 15, 1347–1355 (2022).35535217
49. Wang, F., et al. Correlation between serum 25-OH-vitamin D Level and diabetic foot ulcer in elderly diabetic patients (2022).
50. Wang J Characteristics of bone metabolism indexes in diabetic foot patients and analysis of the effect of surgical treatment Zhejiang Clin. Med. J. 2022 24 9 1363 1366
Wang, J. et al. Characteristics of bone metabolism indexes in diabetic foot patients and analysis of the effect of surgical treatment. Zhejiang Clin. Med. J. 24(9), 1363–1366 (2022).
51. Wu L Analysis of related influencing factors of osteoporosis in diabetic foot patients Diabetes New World. 2015 09 230
Wu, L. et al. Analysis of related influencing factors of osteoporosis in diabetic foot patients. Diabetes New World. 09, 230 (2015).
52. Yoho RM A comparison of vitamin D levels in nondiabetic and diabetic patient populations J. Am. Podiatr. Med. Assoc. 2009 99 1 35 41 10.7547/0980035 19141720
Yoho, R. M. et al. A comparison of vitamin D levels in nondiabetic and diabetic patient populations. J. Am. Podiatr. Med. Assoc. 99(1), 35–41 (2009).19141720
53. Zhang Z Analysis of related influencing factors of osteoporosis in diabetic foot patients Shandong Med. J. 2013 53 21 75 77
Zhang, Z. et al. Analysis of related influencing factors of osteoporosis in diabetic foot patients. Shandong Med. J. 53(21), 75–77 (2013).
54. Zhang D Correlations between serum TLR-9, 25-(OH) D3 levels and blood glucose indexes and disease severity in patients with diabetic foot infection J. North Sichuan Med. College. 2022 37 03 320 323
Zhang, D. et al. Correlations between serum TLR-9, 25-(OH) D3 levels and blood glucose indexes and disease severity in patients with diabetic foot infection. J. North Sichuan Med. College. 37(03), 320–323 (2022).
55. Zubair M 25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship? Diabetes Metab. Syndr. 2013 7 3 148 153 10.1016/j.dsx.2013.06.008 23953180
Zubair, M. et al. 25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship?. Diabetes Metab. Syndr. 7(3), 148–153 (2013).23953180
56. Maggi S Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues Acta Diabetol. 2014 51 3 461 469 10.1007/s00592-013-0540-4 24356952
Maggi, S. et al. Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues. Acta Diabetol. 51(3), 461–469 (2014).24356952
57. Mozaffari-Khosravi H Haratian-Arab M MoeinTavakkoli H Nadjarzadeh A Comparative effect of two different doses of vitamin D on diabetic foot ulcer and inflammatory indices among the type 2 diabetic patients a randomized clinical trial Iranian J. Diabetes Obes. 2017 8 4 164 171
Mozaffari-Khosravi, H., Haratian-Arab, M., MoeinTavakkoli, H. & Nadjarzadeh, A. Comparative effect of two different doses of vitamin D on diabetic foot ulcer and inflammatory indices among the type 2 diabetic patients a randomized clinical trial. Iranian J. Diabetes Obes. 8(4), 164–171 (2017).
58. Razzaghi R The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial J. Diabetes Complicat. 2017 31 4 766 772 10.1016/j.jdiacomp.2016.06.017
Razzaghi, R. et al. The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. J. Diabetes Complicat. 31(4), 766–772 (2017).
59. Ajoinish K To study the effect of oral vitamin D supplements on wound healing in patient with diabetic foot ulcer and its effect on lipid metabolism Int. J. Res. Pharmac. Sci. 2020 11 2 2701 2706 10.26452/ijrps.v11i2.2290
Ajoinish, K. et al. To study the effect of oral vitamin D supplements on wound healing in patient with diabetic foot ulcer and its effect on lipid metabolism. Int. J. Res. Pharmac. Sci. 11(2), 2701–2706 (2020).
60. Halschou-Jensen PM Improved healing of diabetic foot ulcers after high-dose vitamin D: A randomized double-blinded clinical trial Int. J. Low Extrem. Wounds 2021 10.1177/15347346211020268 34213957
Halschou-Jensen, P. M. et al. Improved healing of diabetic foot ulcers after high-dose vitamin D: A randomized double-blinded clinical trial. Int. J. Low Extrem. Wounds10.1177/15347346211020268 (2021).34213957
61. Janoušek J Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites Crit. Rev. Clin. Lab. Sci. 2022 59 8 517 554 10.1080/10408363.2022.2070595 35575431
Janoušek, J. et al. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit. Rev. Clin. Lab. Sci. 59(8), 517–554 (2022).35575431
62. Karampela I Vitamin D and obesity: current evidence and controversies Curr. Obes. Rep. 2021 10 2 162 180 10.1007/s13679-021-00433-1 33792853
Karampela, I. et al. Vitamin D and obesity: current evidence and controversies. Curr. Obes. Rep. 10(2), 162–180 (2021).33792853
63. Bikle DD Vitamin D metabolism and function in the skin Mol. Cell. Endocrinol. 2011 347 1–2 80 89 10.1016/j.mce.2011.05.017 21664236
Bikle, D. D. Vitamin D metabolism and function in the skin. Mol. Cell. Endocrinol. 347(1–2), 80–89 (2011).21664236
64. Oda Y Vitamin D receptor is required for proliferation, migration, and differentiation of epidermal stem cells and progeny during cutaneous wound repair J. Invest. Dermatol. 2018 138 11 2423 2431 10.1016/j.jid.2018.04.033 29787748
Oda, Y. et al. Vitamin D receptor is required for proliferation, migration, and differentiation of epidermal stem cells and progeny during cutaneous wound repair. J. Invest. Dermatol. 138(11), 2423–2431 (2018).29787748
65. Lu X Effects of topical 1,25 and 24,25 vitamin D on diabetic, vitamin D deficient and vitamin D receptor knockout mouse corneal wound healing Biomolecules 2023 13 7 1065 10.3390/biom13071065 37509101
Lu, X. et al. Effects of topical 1,25 and 24,25 vitamin D on diabetic, vitamin D deficient and vitamin D receptor knockout mouse corneal wound healing. Biomolecules 13(7), 1065 (2023).37509101
66. Chang E Effects of vitamin D supplementation on adipose tissue inflammation and NF-κB/ampk activation in obese mice fed a high-fat diet Int. J. Mol. Sci. 2022 23 18 10915 10.3390/ijms231810915 36142842
Chang, E. Effects of vitamin D supplementation on adipose tissue inflammation and NF-κB/ampk activation in obese mice fed a high-fat diet. Int. J. Mol. Sci. 23(18), 10915 (2022).36142842
67. Luderer HF Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury Endocrinology 2013 154 1 16 24 10.1210/en.2012-1579 23132743
Luderer, H. F. et al. Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury. Endocrinology 154(1), 16–24 (2013).23132743
68. Lin R Crosstalk between vitamin D metabolism, VDR signalling, and innate immunity Biomed. Res. Int. 2016 2016 1375858 10.1155/2016/1375858 27403416
Lin, R. Crosstalk between vitamin D metabolism, VDR signalling, and innate immunity. Biomed. Res. Int. 2016, 1375858 (2016).27403416
69. Vanherwegen AS Gysemans C Mathieu C Regulation of immune function by vitamin D and its use in diseases of immunity Endocrinol. Metab. Clin. North Am. 2017 46 4 1061 1094 10.1016/j.ecl.2017.07.010 29080635
Vanherwegen, A. S., Gysemans, C. & Mathieu, C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol. Metab. Clin. North Am. 46(4), 1061–1094 (2017).29080635
70. Trujillo V Calcitriol promotes proangiogenic molecules in keratinocytes in a diabetic foot ulcer model J. Steroid Biochem. Mol. Biol. 2017 174 303 311 10.1016/j.jsbmb.2017.10.013 29042175
Trujillo, V. et al. Calcitriol promotes proangiogenic molecules in keratinocytes in a diabetic foot ulcer model. J. Steroid Biochem. Mol. Biol. 174, 303–311 (2017).29042175
71. Shillo P Reduced vitamin D levels in painful diabetic peripheral neuropathy Diabet. Med. 2019 36 1 44 51 10.1111/dme.13798 30102801
Shillo, P. et al. Reduced vitamin D levels in painful diabetic peripheral neuropathy. Diabet. Med. 36(1), 44–51 (2019).30102801
72. Banafshe HR Vitamin D supplementation attenuates the behavioral scores of neuropathic pain in rats Nutr. Neurosci. 2019 22 10 700 705 10.1080/1028415X.2018.1435485 29431049
Banafshe, H. R. et al. Vitamin D supplementation attenuates the behavioral scores of neuropathic pain in rats. Nutr. Neurosci. 22(10), 700–705 (2019).29431049
73. Huang R Relationship between serum vitamin level and diabetes and diabetic foot J. Hainan Med. Univ. 2019 25 16 1227 1231
Huang, R. et al. Relationship between serum vitamin level and diabetes and diabetic foot. J. Hainan Med. Univ. 25(16), 1227–1231 (2019).
74. Dai J Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis Nutr. Diabetes 2019 9 1 8 10.1038/s41387-019-0078-9 30858355
Dai, J. et al. Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis. Nutr. Diabetes 9(1), 8 (2019).30858355
75. Çağlar S Osteoprotegerin and 25-hydroxy vitamin D levels in patients with diabetic foot Eklem Hastalik Cerrahisi 2018 29 3 170 175 10.5606/ehc.2018.60797 30376802
Çağlar, S. et al. Osteoprotegerin and 25-hydroxy vitamin D levels in patients with diabetic foot. Eklem Hastalik Cerrahisi 29(3), 170–175 (2018).30376802
76. Gallagher JC Vitamin D and aging Endocrinol. Metab. Clin. North Am. 2013 42 2 319 332 10.1016/j.ecl.2013.02.004 23702404
Gallagher, J. C. Vitamin D and aging. Endocrinol. Metab. Clin. North Am. 42(2), 319–332 (2013).23702404
77. Ferri E Vitamin D in physiological and pathological aging: Lesson from centenarians Rev. Endocr. Metab. Disord. 2019 20 3 273 282 10.1007/s11154-019-09522-y 31654261
Ferri, E. et al. Vitamin D in physiological and pathological aging: Lesson from centenarians. Rev. Endocr. Metab. Disord. 20(3), 273–282 (2019).31654261
78. Kostecka D Body Composition analysis in perimenopausal women considering the influence of vitamin D, menstruation, sociodemographic factors, and stimulants used Int. J. Environ. Res. Public Health 2022 19 23 15831 10.3390/ijerph192315831 36497902
Kostecka, D. et al. Body Composition analysis in perimenopausal women considering the influence of vitamin D, menstruation, sociodemographic factors, and stimulants used. Int. J. Environ. Res. Public Health 19(23), 15831 (2022).36497902
79. Yan X Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial Signal Transduct. Target Ther. 2023 8 1 158 10.1038/s41392-023-01369-9 37076476
Yan, X. et al. Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial. Signal Transduct. Target Ther. 8(1), 158 (2023).37076476
80. Li X The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis Nutrients 2018 10 3 375 10.3390/nu10030375 29562681
Li, X. et al. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Nutrients 10(3), 375 (2018).29562681
81. Wu C Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis Metabolism 2017 73 67 76 10.1016/j.metabol.2017.05.006 28732572
Wu, C. et al. Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Metabolism 73, 67–76 (2017).28732572
82. Zaki M Association of vitamin D receptor gene polymorphism (VDR) with vitamin D deficiency, metabolic and inflammatory markers in Egyptian obese women Genes Dis. 2017 4 3 176 182 10.1016/j.gendis.2017.07.002 30258921
Zaki, M. et al. Association of vitamin D receptor gene polymorphism (VDR) with vitamin D deficiency, metabolic and inflammatory markers in Egyptian obese women. Genes Dis. 4(3), 176–182 (2017).30258921
83. Levin GP Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes JAMA 2012 308 18 1898 1905 10.1001/jama.2012.17304 23150009
Levin, G. P. et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA 308(18), 1898–1905 (2012).23150009
84. Ma Y 1,25(OH)(2)D(3) improves diabetic wound healing by modulating inflammation and promoting angiogenesis J. Steroid Biochem. Mol. Biol. 2024 239 106477 10.1016/j.jsbmb.2024.106477 38340904
Ma, Y. et al. 1,25(OH)(2)D(3) improves diabetic wound healing by modulating inflammation and promoting angiogenesis. J. Steroid Biochem. Mol. Biol. 239, 106477 (2024).38340904
85. Wu Y Effects of vitamin D status on cutaneous wound healing through modulation of EMT and ECM J. Nutr. Biochem. 2024 134 109733 10.1016/j.jnutbio.2024.109733 39127309
Wu, Y. et al. Effects of vitamin D status on cutaneous wound healing through modulation of EMT and ECM. J. Nutr. Biochem. 134, 109733 (2024).39127309
